The protein level of AIM2 in high-grade BLCA was significantly lower than that in low-grade BLCA, suggesting that BLCA may evade inflammasome activation by downregulated AIM2 (Figure 1D). The gene discussed is AIM2; the disease is bladder transitional cell carcinoma.